| Species | Species Detail | Cells | Enzyme(s) | Medium |
Reference |
| Human
|
human |
cancer stem cell |
Collagenase Type 3: 200 u/ml
Deoxyribonuclease I: 100 u/ml
|
RPMI-1640 |
Phenotypic characterization of human colorectal cancer stem cells.
,
Proc Natl Acad Sci U S A 104,
10158-63, 2007 |
| Human
|
Human |
colonic endothelial cells |
Collagenase Type 2: 0.25%
|
HBSS/5%FBS |
Expression and Endocytosis of VEGF and Its Receptors in Human Colonic Vascular Endothelial Cells
,
Am J Physiol/Gastro 282,
G1088, 2002 |
| Human
|
human |
colonocytes |
Collagenase:
|
DMEM/F12 |
Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes.
,
J Nutr 46,
96-105, 2001 |
| Mouse
|
mouse, 6-8 week |
cancer stem cell |
Collagenase Type 3: 200 u/ml
Deoxyribonuclease I: 100 u/ml
|
RPMI-1640 |
Phenotypic characterization of human colorectal cancer stem cells.
,
Proc Natl Acad Sci U S A 104,
10158-63, 2007 |
| Mouse
|
mouse |
lympocytes |
Collagenase/Dispase: 100 u/ml
|
RPMI 1640 |
Essential role for CD103 in the T cell-mediated regulation of experimental colitis.
,
J Exp Med 202,
1051, 2005 |
| Mouse
|
mouse, 6-8 week |
lamina propria mononuclear cells |
Collagenase Type 2: 0.015%
Deoxyribonuclease I: 0.01%
|
RPMI |
Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.
,
J Immunol 168(1),
411, 2002 |